BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AVANIR Pharmaceuticals 

11388 Sorrento Valley Road

San Diego  California  92121  U.S.A.
Phone: 858-622-5200 Fax: 858-658-7447


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Healthcare

Segment
Pharmaceuticals





 Company News
AVANIR Pharmaceuticals (AVNR) Release: Through Laughter And Tears Comes First-Ever Documentary About Life With Pseudobulbar Affect (PBA) 12/9/2014 9:30:53 AM
AVANIR Pharmaceuticals (AVNR) Cancels Previously Scheduled Earnings Call 12/8/2014 7:28:00 AM
AVANIR Pharmaceuticals (AVNR) Announces Date Of Fiscal 2014 Fourth Quarter Financial Results And Conference Call 12/2/2014 11:48:10 AM
Otsuka Pharmaceutical Co., Ltd. Buys AVANIR Pharmaceuticals (AVNR) For $3.5 Billion 12/2/2014 6:21:23 AM
AVANIR Pharmaceuticals (AVNR) Receives Complete Response Letter (CRL) From FDA On AVP-825 NDA 12/1/2014 9:15:10 AM
AVANIR Pharmaceuticals (AVNR) Making Strides With Alzheimer’s Drug, Says Analyst 11/24/2014 2:04:45 PM
AVANIR Pharmaceuticals (AVNR) To Participate In Two Conferences In December 11/20/2014 12:29:41 PM
AVANIR Pharmaceuticals (AVNR)'s Migraine Treatment Will Unlikely Win Approval By Scheduled Timeline 11/7/2014 8:31:20 AM
AVANIR Pharmaceuticals (AVNR) Announces Publication Of Pivotal Phase 3 Results From AVP-825 Acute Migraine Study In The Journal "Headache" 10/31/2014 7:26:20 AM
AVANIR Pharmaceuticals (AVNR) Gives Suitors Two Big Reasons To Bid 10/31/2014 6:16:31 AM
12345678910...